Dorothy G. Capers - 04 Mar 2025 Form 4 Insider Report for Xylem Inc. (XYL)

Role: SVP & General Counsel
Signature: /s/ Mike Nazario, by power of attorney for Dorothy G. Capers
Issuer symbol: XYL
Transactions as of: 04 Mar 2025
Net transactions value: +$389,878
Form type: 4
Filing time: 06 Mar 2025, 16:11:05 UTC
Previous filing: 04 Mar 2025
Next filing: 02 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XYL	Common Stock	Options Exercise	$682,628	+7,868	+98%	$86.76	15,883	04 Mar 2025	Direct
transaction	XYL	Common Stock	Options Exercise	$420,332	+4,158	+26%	$101.09	20,041	04 Mar 2025	Direct
transaction	XYL	Common Stock	Sale	$1,530,391	-12,026	-60%	$127.26	8,015	04 Mar 2025	Direct	F1
transaction	XYL	Common Stock	Award	$181,279	+1,398	+17%	$129.67	9,413	05 Mar 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XYL	Non-Qualified Stock Option (Right to Buy)	Options Exercise	$0	-4,158	-67%	$0.000000	2,079	04 Mar 2025	Common Stock	4,158	$101.09	Direct	F3
transaction	XYL	Non-Qualified Stock Option (Right to Buy)	Options Exercise	$0	-7,868	-100%	$0.000000	0	04 Mar 2025	Common Stock	7,868	$86.76	Direct	F4
transaction	XYL	Non-Qualified Stock Options (Right to buy)	Award	$636,031	+4,905		$129.67	4,905	05 Mar 2025	Common Stock	4,905	$129.67	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 12,026 Shares were executed at a range of prices from $125.25 to $125.35. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
F2	Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.
F3	The March 1, 2023 option grant vested 2,079 options on March 1, 2024, 2,079 options on March 1, 2025, and will vest 2,079 options on March 1, 2026.
F4	The March 1, 2022 option grant vested 2,623 options on March 1, 2023, 2,623 options on March 1, 2024, and 2,622 options on March 1, 2025.
F5	Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.